Objectives and participants
Advisory Committee
Implementation Agent
Contact us


In the 2018 Budget, the Hong Kong Special Administrative Region Government set aside $500 million to set up the Chinese Medicine Development Fund (Fund), which is supervised by the Health Bureau. The fund was officially put into operation in June 2019.

Objectives and participants

The main purpose of the Hong Kong Chinese Medicine Development Fund is to promote the development of the Chinese medicine and Chinese medicine drug sectors, enhance the overall standard of the industry, nurture talents for Chinese medicine, promote Chinese medicine-related research and enhance public knowledge and understanding of Chinese medicine. The Fund will benefit  practitioners and organizations at different levels of the Chinese medicine and Chinese medicine drug sectors including Chinese medicine practitioners (covering both registered and listed Chinese medicine practitioners), related healthcare professionals  and persons engaged in the Chinese medicine drug industry. Organizations include Chinese medicine clinics, manufacturers and wholesalers of proprietary Chinese medicine (pCM) , retailers and wholesalers of Chinese herbal medicine, as well as professional bodies, trade associations, institutions related to Chinese medicine, universities and higher education institutions.


The Chinese Medicine Development Fund comprises of two parts, namelythe Enterprise Support Scheme (ESP) and the Industry Support Scheme (ISP). There are four funding schemes under ESP, including funding scheme for "Chinese Medicine Personal Training and Chinese Medicine Clinic Improvement Funding Scheme", the "Proprietary Chinese Medicine Quality and Manufacturing System Enhancement Funding Scheme", the "Proprietary Chinese Medicine Registration Supporting Scheme" and the "Chinese Medicine Warehouse Management, Logistics and Services Improvement Funding Scheme". The ISP is divided into two projects, including "Chinese Medicine Industry Training Funding Scheme & Chinese Medicine Promotion Funding Scheme" and the "Chinese Medicine Applied Studies and Research Funding Scheme".

Advisory Committee

The Committee, for which the Chairman and members are appointed by the Secretary for Health, comprises representatives from the sectors of Chinese medicine practitioners, Chinese medicine drugs, testing and certification, and healthcare, as well as experts, academics and lay persons with rich experience in business management and public administration. The appointments will take effect from March 1, 2021, to February 28, 2023, for a term of two years.

Membership of the Committee is as follows:

Chairman Members Ex-officio Members
Mr SO Cheung-tak Douglas, BBS, JP Professor BIAN Zhaoxiang
Dr CHAN Kei-wai
Mr CHAN Wing-suen
Professor FENG Yibin
Ms LAM Pui-yan
Ms LAU Sze-wan, Serena, JP
Mr LEE Kai-ping, Henry
Dr LIONG Ching
Mr MA Kwai-yung, Gerry, JP
Dr OR Ka-hang
Miss Suen Wai-lam
Ms WANG Huimin
Mr WONG Ka-on
Professor WU Che-yuen, Justin
Representative(s) from the Health Bureau
Representative(s) from the Department of Health
Representative(s) from the Hospital Authority
Representative(s) from the Innovation and Technology Commission


Implementation Agent

The Hong Kong Productivity Council will be serving as the Implementation Agent.

Contact us

HKPC building, 78, Tat Chee Avenue, Kowloon Tong
Tel:2788 5632 (General Enquiries) 2788 5633 (Chinese Medicine Personal Training Funding Scheme A1-1, A1-2, A1-3)
Fax:3187 4581
Email:[email protected]

電話: (852)2788 5632 / 2788 5633 傳真: (852)3187 4581 電郵: [email protected]
copyright @ 2019 Chinese Medicine Development Fund
2022-04-27 加快處理「新型冠狀病毒疫情相關項目」的申請
2022-03-22 2019冠狀病毒病特別支援計劃
中醫藥發展基金特別支援項目「齊心抗疫—中醫藥遙距診療計劃」已經推出!計劃獲食物及衞生局全力支持,由香港中醫中藥界聯合總會主辦及統籌,資助合資格中醫師為2019冠狀病毒病確診人士提供免費遙距中醫藥診療服務,自2022年3月22日起開始接受求診者預約登記。確診人士可 按此 瀏覽診療計劃網上報名專頁。
2022-03-18 中醫藥發展基金「行業支援計劃」獲資助項目分享短片